Showing results (171-180 of 369) with videos related to

Sort By:
Pageof 37
Experimental Hematology|September 1, 1984
Natural killer cell profile of two random-bred strains of athymic ratsE Lotzová, C A Savary, K N Gray, et al.
In Vivo (Athens, Greece)|September 1, 1992
Improved efficacy of doxorubicin by simultaneous treatment with interferon-gamma and interleukin-2A J Lumsden, J P Codde, B N Gray, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 7, 2007
Characteristics of U.S. waterpipe users: a preliminary reportKenneth D Ward, Thomas Eissenberg, Jennifer N Gray, et al.
The Medical Journal of Australia|March 21, 1994
Traffic and noise in children's wardsR T Couper, K Hendy, N Lloyd, et al.
International Journal of Medical Microbiology : IJMM|April 30, 2023
Longitudinal relationship between the gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) following pediatric allogeneic hematopoietic cell transplantation (HCT) - Case seriesAshley N Gray, Nicole H Tobin, Theodore B Moore, et al.
Journal of Bacteriology|December 3, 2008
Contribution of the periplasmic chaperone Skp to efficient presentation of the autotransporter IcsA on the surface of Shigella flexneriJennifer K Wagner, Jason E Heindl, Andrew N Gray, et al.
Annals of the New York Academy of Sciences|November 23, 2006
The health watch case-control study of leukemia and benzene: the story so farDeborah C Glass, Christopher N Gray, Damien J Jolley, et al.
Carbon Balance and Management|June 2, 2015
Effects of harvest, fire, and pest/pathogen disturbances on the West Cascades ecoregion carbon balanceDavid P Turner, William D Ritts, Robert E Kennedy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Can current models explain the lack of liver complications in Y-90 microsphere therapy?E D Yorke, A Jackson, R A Fox, et al.
Anticancer Research|May 1, 1996
Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gammaA J Lumsden, J P Codde, P H Van der Meide, et al.
Pageof 37